Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

10.13 +0.40 (+4.11%)

Official Closing Price Updated: 4:15 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street ↗

October 17, 2024

Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.

Via The Motley Fool

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street ↗

October 09, 2024

These stocks haven't performed well this year.

Via The Motley Fool

2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk ↗

September 29, 2024

The Ark Invest portfolio is known for taking aggressive bets.

Via The Motley Fool

Expert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts ↗

September 11, 2024

Via Benzinga

Expert Ratings For Intellia Therapeutics ↗

August 12, 2024

Via Benzinga

3 Gene Editing Stocks with Potential to Transform Medicine ↗

August 09, 2024

Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks.

Via InvestorPlace

Unveiling 6 Analyst Insights On Intellia Therapeutics ↗

June 24, 2024

Via Benzinga

NTLA Stock Earnings: Intellia Therapeutics Misses EPS, Misses Revenue for Q2 2024 ↗

August 08, 2024

NTLA stock results show that Intellia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

August 01, 2024

Via The Motley Fool

7 Biotech Stocks to Keep on Your Clinical Radar ↗

July 23, 2024

Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.

Via InvestorPlace

3 Gene Editing Stocks That Could Grow Your Wealth ↗

July 17, 2024

Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks.

Via InvestorPlace

3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition ↗

July 17, 2024

Explore gene-editing stocks with potential to become multibaggers as the industry advances in treating genetic disorders.

Via InvestorPlace

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

3 Profitable CRISPR Stocks Earning Analysts’ Praise ↗

July 09, 2024

Revolutionary gene-editing technologies provide promise for investors seeking the most profitable CRISPR stocks today and in the future.

Via InvestorPlace

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗

July 09, 2024

Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.

Via InvestorPlace

The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger ↗

July 09, 2024

An improbable but serious risk facing the company's investors just got minimized.

Via The Motley Fool

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.

Via InvestorPlace

3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗

July 08, 2024

So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider.

Via InvestorPlace

The 3 Best Biotech Stocks to Buy in July 2024 ↗

July 05, 2024

For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024.

Via InvestorPlace

Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally ↗

July 03, 2024

Via Benzinga

Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗

July 02, 2024

Via Benzinga

3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024 ↗

July 02, 2024

Via The Motley Fool

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet ↗

June 28, 2024

Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.

Via InvestorPlace

You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever. ↗

June 27, 2024

The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.

Via InvestorPlace

Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump ↗

June 26, 2024

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market.

Via Benzinga

3 Gene Editing Stocks That Could Make Your Grandchildren Rich ↗

June 25, 2024

Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions.

Via InvestorPlace

RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

June 24, 2024

Via Benzinga

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗

June 24, 2024

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Via Benzinga

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024 ↗

June 21, 2024

Investors looking for companies with high growth potential should consider investing in these three strong buy Cathie Wood stocks.

Via InvestorPlace

Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio? ↗

June 16, 2024

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, CleanSpark, Enovix Corp, Axcelis Tech, Intellia Therapeutics, Korn Ferry.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.